Gastrointestinal cancer: Rationale for metronomic chemotherapy in phase III trials

Robert S. Kerbel, Axel Grothey

Research output: Contribution to journal › Short survey › peer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'Gastrointestinal cancer: Rationale for metronomic chemotherapy in phase III trials'. Together they form a unique fingerprint.